Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Aichi Medical University, Nagakute, Japan

1 abstract

Abstract
Impact of histology on the efficacy and safety of pembrolizumab (pembro) monotherapy for advanced urothelial carcinoma (UC) in the phase 3 KEYNOTE-045 and KEYNOTE-361 trials.
Org: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Cliniques Universitaires Saint-Luc (UCLouvain), Brussels, Belgium, Aichi Medical University, Nagakute, Japan, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Tokyo Medical and Dental University Hospital, Tokyo, Japan,